Pro-Nifuroxazide was first used as an antibiotic agent for diarrhea or colitis which reduces kinase phosphorylation in the bone marrow, resulting in the downregulation of the signal transducer and activator of transcription 3 (STAT-3) target gene mcl-1 [160, 161]. Here, STAT3 is linked to colitis.